Cellyan Biotechnology Co., Ltd
Calidad de datos: 17%
HKPD
NASDAQ
Wholesale Trade
Nondurable Goods Wholesale
$0.68
▲
$0.04
(5.64%)
Cap. Mercado: 13.09 M
6 months return
—
Momentum
Neutral
Quick Summary
Price History
Comparación con Pares
vs mediana del sector Wholesale Trade (100 pares)
Comparado con empresas similares en Wholesale Trade
Comparación con Pares
vs mediana del sector Wholesale Trade (100 pares) Comparado con empresas similares en Wholesale Trade| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | — | -0.2 |
| P/B | — | 1.0 |
| ROE % | — | -3.2 |
| Net Margin % | — | -2.4 |
| Rev Growth 5Y % | — | 2.6 |
| D/E | — | 0.3 |
Precio Objetivo de Analistas
Consenso de analistas: objetivo medio vs precio actual y calificación.
No hay cobertura de analistas disponible
Estimaciones de Ganancias
Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.
No hay estimaciones futuras disponibles
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | N/A |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | N/A |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | N/A |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | N/A | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | N/A | ||
| Market Cap | 13.09 M | Enterprise Value | N/A |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
{"event":"ticker_viewed","properties":{"ticker":"HKPD","listing_kind":"stock","pathname":"/stocks/hkpd","exchange":"NASDAQ","country":"US"}}